| scholarly article | Q13442814 |
| P50 | author | Estela Paz-Artal | Q40630377 |
| Francisco López-Medrano | Q40630411 | ||
| Carlos Lumbreras | Q56867788 | ||
| Rafael San-Juan | Q92281883 | ||
| Ana Garcia-Reyne | Q114777150 | ||
| P2093 | author name string | Mario Fernández-Ruiz | |
| Amado Andrés | |||
| José M Morales | |||
| José M Aguado | |||
| Luis M Allende | |||
| P2860 | cites work | Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors | Q24648099 |
| Factors influencing long-term outcome after kidney transplantation | Q26825480 | ||
| State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician | Q27014778 | ||
| Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation. | Q33834302 | ||
| A review of critical periods for opportunistic infection in the new transplantation era. | Q36681922 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Infectious complications of antilymphocyte therapies in solid organ transplantation | Q37389518 | ||
| International consensus guidelines on the management of cytomegalovirus in solid organ transplantation | Q37707986 | ||
| Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review | Q37801006 | ||
| Nocardia infection in kidney transplant recipients: case report and analysis of 66 published cases | Q37913494 | ||
| GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. | Q37934102 | ||
| Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis | Q37987320 | ||
| Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients | Q42262587 | ||
| Hypocomplementemia in kidney transplant recipients: impact on the risk of infectious complications | Q42279119 | ||
| Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study | Q42284503 | ||
| An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia. | Q42286792 | ||
| Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study | Q43204905 | ||
| Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. | Q43595088 | ||
| Long-term effects of ATG therapy on lymphocyte subsets | Q43620723 | ||
| American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation | Q44495127 | ||
| Infection-related mortality in a large cohort of renal transplant recipients. | Q44892095 | ||
| Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation | Q44992663 | ||
| Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients | Q46685919 | ||
| Pneumocystis jirovecii colonization and infection among non HIV-infected patients. | Q51013373 | ||
| Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. | Q51484049 | ||
| Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation. | Q51890070 | ||
| Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients | Q57568967 | ||
| Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort | Q57569151 | ||
| Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody | Q59230712 | ||
| P433 | issue | 7 | |
| P921 | main subject | opportunistic infection | Q835718 |
| P304 | page(s) | 674-685 | |
| P577 | publication date | 2014-04-25 | |
| P1433 | published in | Transplant International | Q15762140 |
| P1476 | title | Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation | |
| P478 | volume | 27 |
| Q52720278 | Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients. |
| Q48334482 | Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload |
| Q55408845 | CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients. |
| Q90518646 | Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence |
| Q40153750 | Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome |
| Q90403930 | Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy |
| Q40721769 | Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications |
| Q92618776 | Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients |
| Q47180135 | Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes. |
| Q87862433 | Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study |
| Q47560250 | Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients |
| Q41994978 | Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study |
| Q54503112 | Immune risk phenotype in kidney transplant recipients: a reliable surrogate for premature immune senescence and increased susceptibility to infection? |
| Q30372284 | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. |
| Q54261725 | In vitro intracellular IFNγ, IL-17 and IL-10 producing T cells correlates with the occurrence of post-transplant opportunistic infection in liver and kidney recipients. |
| Q40912977 | Infectious Complications Following Small Bowel Transplantation |
| Q50998540 | Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates. |
| Q54714956 | Low Natural Killer Cell Counts and Onset of Invasive Fungal Disease After Solid Organ Transplantation. |
| Q40630330 | Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients |
| Q40645930 | Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients |
| Q57568519 | Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study |
| Q90776878 | Sepsis is associated with lack of monocyte HLA-DR expression recovery without modulating T-cell reconstitution after lung transplantation |
| Q40358580 | Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation |
| Q41090910 | T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation |
| Q36151396 | The CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort |
Search more.